<DOC>
	<DOCNO>NCT01540058</DOCNO>
	<brief_summary>This european randomise , phase III , multi-centric study compare diagnostic therapeutic strategy base molecular analysis follow suspected primary cancer tailor specific therapy , empiric strategy patient carcinoma unknown primary . The purpose trial determine whether strategy base molecular analysis effective improve progression free survival rate patient carcinoma unknown primary ( CUP ) .</brief_summary>
	<brief_title>Trial Comparing Strategy Based Molecular Analysis Empiric Strategy Patients With CUP</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms , Unknown Primary</mesh_term>
	<criteria>1 . Patients present carcinoma unknown primary , confirm histopathological analysis ( include immunohistochemical analysis ) correspond one follow histologic type : moderately welldifferentiated adenocarcinoma , poorlydifferentiated adenocarcinoma , undifferentiated carcinoma , squamouscell carcinoma 2 . Diagnostic workup keep Standard Options Recommandations de CAPI ( Lesimple et al. , 2003 ) , 3 . Age &gt; 18 year , 4 . Performance Status 0 , 1 2 accord ECOG 5 . Good poor prognosis CUP classify accord GEFCAPI classification 6 . CUP least one measurable lesion 7 . Tumour sample available molecular analysis 8 . CUP belong subgroup require specific treatment , 9 . Satisfactory haematological , renal hepatic function 10 . Cardiac , respiratory neurological function compatible administration cisplatin chemotherapy , 11 . No previous chemotherapy CUP 12 . Previous radiotherapy acceptable , complete least 4 week start systemic treatment . Randomization perform time frame . 13 . All patient reproductive potential must practice effective method birth control throughout study . Female patient childbearing potential must negative pregnancy test within 7 day study treatment 14 . Information deliver patient inform consent form sign patient legal representative . 1 . Patients diagnosis histologically confirm ( cytological analysis alone permit patient entry onto trial ) , 2 . Patients know HIV infection 3 . Patients symptomatic brain metastasis , 4 . Associated disease likely prevent patient receive treatment , 5 . Previous history cancer ( except skin basocellular epithelioma epithelioma situ uterine cervix ) 5 year study entry , 6 . Patients already include another clinical trial experimental therapy , 7 . Pregnant woman woman breastfeeding , 8 . Compliance trial medical followup impossible due geographic , social psychological reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>